Inventor
PHADKE DEEPAK
US18 patents
⚠️ This page may combine multiple inventors who share the name “PHADKE DEEPAK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VANDA PHARMACEUTICALS INC
17 patentsUS10829465B2Nov 10, 2020
Highly purified pharmaceutical grade tasimelteon
VANDA PHARMACEUTICALS INC10 citations90
US10611744B2Apr 7, 2020
Highly purified pharmaceutical grade tasimelteon
VANDA PHARMACEUTICALS INC10 citations90
US10071977B2Sep 11, 2018
Highly purifid pharmaceutical grade tasimelteon
VANDA PHARMACEUTICALS INC14 citations90
US9212129B2Dec 15, 2015
Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
VANDA PHARMACEUTICALS INC5 citations83
US12447141B2Oct 21, 2025
Liquid tasimelteon formulations and methods of use thereof
VANDA PHARMACEUTICALS INC1 citations72
US11760740B2Sep 19, 2023
Highly purified pharmaceutical grade tasimelteon
VANDA PHARMACEUTICALS INC1 citations71
US11759446B2Sep 19, 2023
Liquid tasimelteon formulations and methods of use thereof
VANDA PHARMACEUTICALS INC2 citations71
US11566011B2Jan 31, 2023
Highly purified pharmaceutical grade tasimelteon
VANDA PHARMACEUTICALS INC1 citations71
US11203581B2Dec 21, 2021
Highly purified pharmaceutical grade tasimelteon
VANDA PHARMACEUTICALS INC1 citations71
US10874659B2Dec 29, 2020
Iloperidone metabolite for use in the treatment of psychiatric disorders
VANDA PHARMACEUTICALS INC6 citations71
US9617203B2Apr 11, 2017
Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
VANDA PHARMACEUTICALS INC1 citations62
US12440470B2Oct 14, 2025
Liquid tasimelteon formulations and methods of use thereof
VANDA PHARMACEUTICALS INC0 citations60
US12049457B2Jul 30, 2024
Highly purified pharmaceutical grade tasimelteon
VANDA PHARMACEUTICALS INC0 citations60
US11202770B2Dec 21, 2021
Liquid tasimelteon formulations and methods of use thereof
VANDA PHARMACEUTICALS INC0 citations60
US10233142B2Mar 19, 2019
Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
VANDA PHARMACEUTICALS INC0 citations51
US9850199B2Dec 26, 2017
Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
VANDA PHARMACEUTICALS INC0 citations51
US12304896B2May 20, 2025
Highly purified pharmaceutical grade tasimelteon
VANDA PHARMACEUTICALS INC0 citations50